Condividi contenuti The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Aggiornato: 13 min 3 sec fa

Debiotech and Fresenius Medical Care Announce Exclusive Partnership for New Home Dialysis Product Development

Mar, 11/03/2015 - 13:41
LAUSANNE, Switzerland and BAD HOMBURG, Germany, November 3, 2015 -- (Healthcare Sales & Marketing Network) -- Debiotech SA, a Swiss medical device developer with expertise in innovative technologies and miniaturized medical equipment and devices, and Fres...
Debiotech, Fresenius Medical Care, dialysis, peritoneal dialysis

CureVac raises $110 Million in a private placement

Mar, 11/03/2015 - 13:36
Further investment for development of mRNA products in cancer immunotherapy and prophylactic vaccines (RNActive®) and molecular therapies (RNArt®) CureVac changes legal form from limited liability company (GmbH) to joint stock company (AG) TU...
Biopharmaceuticals, Oncology, Venture Capital
CureVac , RNActive, RNArt

BME Launches the Speed(TM) Hand and Wrist System Specifically Designed for Hand and Wrist Surgery

Lun, 11/02/2015 - 15:45
SAN ANTONIO, Nov. 2, 2015 -- (Healthcare Sales & Marketing Network) -- BioMedical Enterprises (BME) announced today the launch of the new Speed™ Hand and Wrist System. The latest addition to BME's Speed system is optimized for hand and wrist applications...
Devices, Orthopaedic, Product Launch
BioMedical Enterprises, BME, Speed Hand and Wrist System

SI-BONE, Inc.(R) Announces Increased Medicare Payments for Hospital Outpatient and Physicians for MIS SIJ Fusion Surgery

Lun, 11/02/2015 - 15:43
Three Additional Medicare Administrative Contractors Move Toward Positive Local Coverage Determinations for Another 16 Million Americans SAN JOSE, Calif., Nov. 2, 2015 -- (Healthcare Sales & Marketing Network) -- SI-BONE, Inc., a medical device company...
Devices, Orthopaedic, Neurosurgery, Reimbursement
SI-BONE, iFuse Implant System, sacroiliac

EnteroMedics Announces Dan Gladney Appointed President and Chief Executive Officer

Lun, 11/02/2015 - 15:40
ST. PAUL, Minn., Nov. 2, 2015 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced...
Devices, Gastroenterology, Personnel
EnteroMedics, vBloc, Neurometabolic Therapy

Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.

Lun, 11/02/2015 - 14:38
Gains full rights to Cardioxyl’s novel nitroxyl (HNO) donor in Phase 2 development for acute decompensated heart failure Strengthens Bristol-Myers Squibb’s pipeline and strategic focus on heart failure NEW YORK & CHAPEL HILL, N.C.--(Healthcare Sales ...
Biopharmaceuticals, Cardiology, Mergers & Acquisitions
Bristol-Myers Squibb, Cardioxyl Pharmaceuticals, CXL-1427, ADHF

New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting

Lun, 11/02/2015 - 14:30
Excellent Treatment Outcomes for a Wide Range of Tumor Types Demonstrated by Accuray CyberKnife and TomoTherapy Systems SUNNYVALE, Calif., Nov. 2, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that studie...
Devices, Oncology
Accuray, CyberKnife, TomoTherapy

Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio

Lun, 11/02/2015 - 13:45
Lead pipeline product, DX-2930, is a Phase 3-ready asset, offering potentially transformative prophylactic therapy for HAE DUBLIN and BURLINGTON, Massachusetts, November 2, 2015 -- (Healthcare Sales & Marketing Network) --Shire plc (LSE: SHP, NASDAQ: S...
Biopharmaceuticals, Mergers & Acquisitions
Shire plc, Dyax, DX-2930, Hereditary Angioedema

PDI Enters Definitive Agreement to Sell Its Commercial Services Business to Publicis Healthcare Communications Group

Lun, 11/02/2015 - 13:12
PDI to Focus on Growing Molecular Diagnostics Business; Plans to Change Name to Interpace Diagnostics Group PDI to receive $25.5 to $32.5 million up front cash payment and a contingent earnout payment Combination Would Create A Global Leader in Healt...
Diagnostics, Acquisitions
PDI Inc, Publicis Healthcare Communications Group, Interpace Diagnostics Group

Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization

Ven, 10/30/2015 - 21:57
TARRYTOWN, N.Y., Oct. 30, 2015 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare has received European approval for EYLEA® (aflibercept) Injection for the treatment of vis...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept

Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business

Ven, 10/30/2015 - 21:33
HERTFORDSHIRE, England and PITTSBURGH, Oct. 30, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (MYL), a leading global pharmaceutical company, today announced the appointment of Ranjan Ray Chaudhuri to serve as global commercial lead of the ...
Biopharmaceuticals, Personnel

Mallinckrodt's INOmax(R) Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery

Ven, 10/30/2015 - 17:52
Approved indication in Australia expanded to include use of INOmax for peri- and post-operative pulmonary hypertension in conjunction with cardiovascular surgery in infants and children up to age 17 Approved indication in Japan expanded to include use o...
Biopharmaceuticals, Regulatory
Mallinckrodt, INOmax, nitric oxide, pulmonary hypertension

Transcend Medical and Glaukos Corporation Settle Patent Litigation

Ven, 10/30/2015 - 13:57
MENLO PARK, CA--(Healthcare Sales & Marketing Network) - Transcend Medical, Inc. (“Transcend”) announced today that it has reached agreement with Glaukos Corporation (“Glaukos”) to settle the patent litigation pending between them in the U.S. District Cour...
Devices, Ophthalmology, Litigation
Transcend Medical, Glaukos, CyPass, Micro-Stent

Celgene’s VIDAZA(R) (Azacitidine for Injection) Approved by the European Commission as New Treatment for Elderly Patients with Acute Myeloid Leukaemia

Ven, 10/30/2015 - 13:50
Expanded indication brings medicine to greater number of elderly AML patients who are not eligible for haematopoietic stem cell transplantation and have >30% myeloblasts in their bone marrow BOUDRY, Switzerland--(Healthcare Sales & Marketing Network)...
Biopharmaceuticals, Oncology, Regulatory
Celgene, VIDAZA, azacitidine, acute myeloid leukaemia

Pfizer Announcement Regarding Allergan plc

Gio, 10/29/2015 - 15:37
Biopharmaceuticals, Mergers & Acquisitions
Pfizer, Allergan

Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.

Gio, 10/29/2015 - 15:28
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 (THE "IRISH TAKEOVER RULES"). DUBLIN, Oct. 29, 2015 -- (Healthcare Sales & Marketing Network) -- Allergan plc today confirmed that it has b...
Biopharmaceuticals, Mergers & Acquisitions
Allergan, Pfizer

BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs

Gio, 10/29/2015 - 15:21
Life science veteran brings 30 years of experience managing development through commercialization of breakthrough dermatology, pharmaceutical and medical device products MENLO PARK, Calif., Oct. 29, 2015 -- (Healthcare Sales & Marketing Network) -- Bio...
Biopharmaceuticals, Dermatology, Personnel

CASMED Sells Vital Signs Monitoring Line, Tightens Focus on FORE-SIGHT Cerebral Oximetry Business

Gio, 10/29/2015 - 15:19
BRANFORD, Conn., Oct. 29, 2015 -- (Healthcare Sales & Marketing Network) -- CAS Medical Systems, Inc. (CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the sale of assets related to its 740 SELECT(R) vital signs mo...
Devices, Monitoring, Neurosurgery, Acqusitions
CAS Medical Systems, CASMED, Zoe Medical, FORE-SIGHT, Cerebral Oximeter

Anika Appoints Richard Hague to Role of Chief Commercial Officer

Gio, 10/29/2015 - 15:14
Industry Veteran to Oversee Further Global Expansion of Commercial Platform, Strengthening of Commercial Partnerships, and Development of Direct Commercial Capability BEDFORD, Mass.--(Healthcare Sales & Marketing Network)--Anika Therapeutics, Inc., (ANI...
Devices, Orthopaedic, Personnel
Anika Therapeutics, hyaluronic acid, ORTHOVISC, MONOVISC

Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing

Gio, 10/29/2015 - 15:08
HOUSTON--(Healthcare Sales & Marketing Network)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the appointment of Alan K. Smith...
Biopharmaceuticals, Oncology, Personnel
Bellicum Pharmaceuticals, Chemical Induction of Dimerization

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong